179 related articles for article (PubMed ID: 37356997)
21. CD34+ Stem Cell Selection and CD3+ T Cell Add-Back from Matched Unrelated Adult Donors in Children with Primary Immunodeficiencies and Hematological Diseases.
Porta F; Comini M; Soncini E; Carracchia G; Maffeis M; Pintabona V; Bolda F; Beghin A; Schumacher RF; Lanfranchi A
Transplant Cell Ther; 2021 May; 27(5):426.e1-426.e9. PubMed ID: 33965183
[TBL] [Abstract][Full Text] [Related]
22. Risk factors and survival analysis for central nervous system complications after allogeneic hematopoietic stem cell transplantation.
Chen X; Peng M; Fu B; Chen Y; Hua J; Zeng C; Xu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 45(10):1176-1184. PubMed ID: 33268578
[TBL] [Abstract][Full Text] [Related]
23. Emergency Department Utilization Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Longitudinal Analysis of 557 Patients.
Cserna J; Baumann CK; Lobmeyr E; Grafeneder J; Ettl F; Eibensteiner F; Rabitsch W; Mitterbauer M; Knaus HA; Wohlfarth P
Transplant Cell Ther; 2023 May; 29(5):321.e1-321.e9. PubMed ID: 36842484
[TBL] [Abstract][Full Text] [Related]
24. Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics.
Keklik F; Alrawi EB; Cao Q; Bejanyan N; Rashidi A; Lazaryan A; Arndt P; Dincer EH; Bachanova V; Warlick ED; MacMillan ML; Arora M; Miller J; Brunstein CG; Weisdorf DJ; Ustun C
Haematologica; 2018 Dec; 103(12):2109-2115. PubMed ID: 30076172
[TBL] [Abstract][Full Text] [Related]
25. Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival.
Khan SA; Gaa B; Pollock BH; Shea B; Reddy V; Wingard JR; Moreb JS
Biol Blood Marrow Transplant; 2001; 7(8):433-8. PubMed ID: 11569888
[TBL] [Abstract][Full Text] [Related]
26. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
27. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
28. [HLA-10/10 matched unrelated donor versus sibling donor hematopoietic stem cell transplantation for adult acute myeloid leukemia].
Yao JF; Zhang GX; Shen YY; Zhang RL; He Y; Wei JL; Jiang EL; Yang DL; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):460-466. PubMed ID: 31340617
[No Abstract] [Full Text] [Related]
29. Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Li T; Luo C; Zhang J; Wei L; Sun W; Xie Q; Liu Y; Zhao Y; Xu S; Wang L
Stem Cell Res Ther; 2021 Apr; 12(1):246. PubMed ID: 33879242
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell Transplant compared with matched sibling and unrelated donor.
Lv W; Fan Z; Huang F; Xu N; Xuan L; GuopanYu ; Jiang Q; Zhou H; Lin R; Zhang X; Sun J; Liu Q
Oncotarget; 2017 Apr; 8(16):26505-26514. PubMed ID: 28460445
[TBL] [Abstract][Full Text] [Related]
31. Risk Factors for and the Prognostic Impact of Pericardial Effusion after Allogeneic Hematopoietic Stem Cell Transplantation.
Kubo H; Imataki O; Fukumoto T; Oku M; Ishida T; Kubo YH; Kida JI; Uemura M; Fujita H; Ohno H; Ide M; Ohnishi H; Kadowaki N
Transplant Cell Ther; 2021 Nov; 27(11):949.e1-949.e8. PubMed ID: 34333179
[TBL] [Abstract][Full Text] [Related]
32. Teniposide-intensified hematopoietic stem cell transplantation with acute graft versus host disease prophylaxis with anti-thymocyte globulin provides good results in high-risk or refractory recurrent hematopoietic malignant diseases.
Wang WJ; Cheng HY; Yang F; Li TT; Yang YX; Zhang YF; Wang JB
Ann Palliat Med; 2021 Nov; 10(11):11798-11807. PubMed ID: 34872304
[TBL] [Abstract][Full Text] [Related]
33. Haploidentical hematopoietic stem cell transplantation for patients with myeloid sarcoma: a single center retrospective study.
Yu WJ; Sun YQ; Han TT; Ye PP; Zhang XH; Xu LP; Liu KY; Yan CH; Huang XJ; Wang Y
Ann Hematol; 2021 Mar; 100(3):799-808. PubMed ID: 33416901
[TBL] [Abstract][Full Text] [Related]
34. Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders.
Biagi E; Zama D; Rampelli S; Turroni S; Brigidi P; Consolandi C; Severgnini M; Picotti E; Gasperini P; Merli P; Decembrino N; Zecca M; Cesaro S; Faraci M; Prete A; Locatelli F; Pession A; Candela M; Masetti R
BMC Med Genomics; 2019 Mar; 12(1):49. PubMed ID: 30845942
[TBL] [Abstract][Full Text] [Related]
35. Engraftment syndrome following Hematopoietic stem cell transplantation: a systematic approach toward diagnosis and management.
Maqbool S; Nadeem M; Shahroz A; Naimat K; Khan I; Tahir H; Rehman A; Anwer F; Iftikhar R; Lee KY
Med Oncol; 2022 Dec; 40(1):36. PubMed ID: 36460884
[TBL] [Abstract][Full Text] [Related]
36. [Hematopoietic reconstitution on the prognosis of hematological malignancies after allogeneic hematopoietic stem cell transplantation].
Zhang Y; Ren HY; Qiu ZX; Wang MJ; Xu WL; Liu W; Li Y; Dong YJ; Yin Y; Sun YH; Wang LH; Ou JP; Wang WS; Cen XN
Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):747-50. PubMed ID: 23336230
[TBL] [Abstract][Full Text] [Related]
37. Incidence and characteristics of engraftment syndrome after autologous hematopoietic cell transplantation in light chain amyloidosis.
Badar T; Khan MA; Szabo A; Drobyski W; Chhabra S; Dhakal B; Fenske TS; Hamadani M; Hari P; Jerkins JH; Shah NN; Shaw BE; D'Souza A
Amyloid; 2019 Dec; 26(4):210-215. PubMed ID: 31347424
[TBL] [Abstract][Full Text] [Related]
38. Engraftment syndrome after allogeneic stem cell transplantation: a systematic review and meta-analysis.
ElGohary G; Toor AA; Gergis U
Bone Marrow Transplant; 2023 Jan; 58(1):1-9. PubMed ID: 36284212
[TBL] [Abstract][Full Text] [Related]
39. [The clinical analysis of haploidentical stem cell transplantation in myelodysplastic syndrome-associated acute myeloid leukemia].
Fei Q; Huang XJ; Liu Y; Xu LP; Zhang XH; Liu KY; Chen H; Chen YY; Wang Y
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):546-551. PubMed ID: 30122012
[No Abstract] [Full Text] [Related]
40. [Allogeneic hematopoietic stem cell transplantation for treatment of refractory and relapsed acute myeloid leukemia: outcomes and prognostic factors].
Su XH; Yao JF; Zhang GX; He Y; Wei JL; Ma QL; Yang DL; Huang Y; Zhai WH; Liang C; Li G; Chen X; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2017 Dec; 38(12):1024-1030. PubMed ID: 29365394
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
